| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|
| Revenue | $20.5B | $20.0B | $19.3B | $16.7B | $3.9B | $3.5B | $3.4B |
| Cost of Revenue | $16.7B | $16.3B | $15.9B | $13.6B | $12.5B | $10.8B | $10.6B |
| Gross Profit | — | — | — | — | $0.7B | $0.6B | $0.6B |
| R&D Expense | — | — | — | — | — | — | — |
| SG&A Expense | $3.0B | $2.8B | $2.7B | $2.4B | $2.3B | $2.1B | $2.1B |
| Operating Income | $0.8B | $0.8B | $0.7B | $0.6B | $0.6B | $0.4B | $0.3B |
| Net Income | $0.5B | $0.5B | $0.5B | $0.4B | $0.1B | $0.0B | $0.1B |
| EPS (Basic) | $4.04 | $3.94 | $3.83 | $3.15 | $0.71 | $0.31 | $0.47 |
| EPS (Diluted) | $4.00 | $3.88 | $3.76 | $3.09 | $0.69 | $0.30 | $0.46 |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|
| Total Assets | $7.1B | $6.7B | $6.3B | $5.7B | $5.4B | $5.3B | $3.2B |
| Current Assets | $1.9B | $1.8B | $1.7B | $1.5B | $1.5B | $1.4B | $1.3B |
| Cash & Equivalents | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Total Liabilities | — | — | — | — | — | — | — |
| Current Liabilities | $2.5B | $2.5B | $2.5B | $2.0B | $2.0B | $1.8B | $1.6B |
| Stockholders' Equity | $1.8B | $1.5B | $1.0B | $0.6B | $0.3B | $-0.1B | $-0.2B |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.9B | $0.7B | $0.8B | $0.8B | $0.9B | $0.4B | $0.4B |
| Investing Cash Flow | $-0.6B | $-0.5B | $-0.7B | $-0.3B | $-0.2B | $-0.2B | $-0.1B |
| Capital Expenditures | $0.6B | $0.5B | $0.4B | $0.3B | $0.2B | $0.2B | $0.1B |
| Financing Cash Flow | $-0.3B | $-0.3B | $-0.1B | $-0.5B | $-0.7B | $-0.2B | $-0.3B |